Burcin Kaymaz-Tezcanli
Ege, Turkey
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Targeting STAT5A via CRISPR/Cas9 restores TKI sensitivity in resistant chronic myeloid leukemia cells.
Journal: Medical oncology (Northwood, London, England)
Published: October 24, 2025
Targeting leukemic stem cells: enhanced eradication via tivantinib (ARQ197) and asciminib (ABL001) with molecular docking-guided screening of therapeutic derivatives.
Journal: Journal of chemotherapy (Florence, Italy)
Published: July 25, 2025
Ponatinib and STAT5 Inhibitor Pimozide Combined Synergistic Treatment Applications Potentially Overcome Drug Resistance via Regulating the Cytokine Expressional Network in Chronic Myeloid Leukemia Cells.
Journal: Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research
Published: April 05, 2024
HDAC inhibitor Vorinostat and BET inhibitor Plx51107 epigenetic agents' combined treatments exert a therapeutic approach upon acute myeloid leukemia cell model.
Journal: Medical oncology (Northwood, London, England)
Published: August 19, 2022
Investigating the Effects of a Synthetic Cannabinoid on the Pathogenesis of Leukemia and Leukemic Stem Cells: A New Therapeutic Approach.
Journal: Cannabis and cannabinoid research
Published: July 14, 2022
Investigating the potential therapeutic role of targeting STAT3 for overcoming drug resistance by regulating energy metabolism in chronic myeloid leukemia cells.
Journal: Iranian journal of basic medical sciences
Published: March 01, 2022
Targeting UPR signaling pathway by dasatinib as a promising therapeutic approach in chronic myeloid leukemia.
Journal: Medical oncology (Northwood, London, England)
Published: March 01, 2022
STAT5 inhibitor Pimozide as a probable therapeutic option in overcoming Ponatinib resistance in K562 leukemic cells.
Journal: Journal of biomolecular structure & dynamics
Published: November 29, 2021
miR-15a enhances the anticancer effects of cisplatin in the resistant non-small cell lung cancer cells.
Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
Published: July 22, 2015
Revealing genome-wide mRNA and microRNA expression patterns in leukemic cells highlighted "hsa-miR-2278" as a tumor suppressor for regain of chemotherapeutic imatinib response due to targeting STAT5A.
Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
Published: April 15, 2015
Capsaicin induced apoptosis and gene expression dysregulation of human acute lymphoblastic leukemia CCRF-CEM cells.
Journal: Journal of B.U.ON. : official journal of the Balkan Union of Oncology
Published: March 25, 2014
Last Updated: 09/26/2026